Self-funded employers bear the financial responsibility of providing healthcare to their employees. This model offers greater control over benefits and potential cost savings. However, the unpredictability and high costs associated with cancer treatments can pose substantial financial risks. Effective cost management and positive health outcomes are key considerations, making it essential to consider how your self-funded plan will manage cancer cases.
To benefit both the employee battling illness and the self-funded employer, oncology management programs need to take a comprehensive approach to care.
Cancer remains one of the most common and costly health conditions affecting employer-sponsored health plans. According to the American Cancer Society, more than 2 million new cancer cases are expected to be diagnosed in the United States each year, while advancements in treatment continue to improve survival rates and extend the duration of care required.
For self-funded employers, cancer often represents one of the largest contributors to catastrophic claims. Recent stop loss industry data shows that oncology consistently ranks as the leading driver of large claims, accounting for a significant portion of claimants exceeding $250,000, $500,000, and even $1 million in annual spend.
The financial burden continues to grow. The National Cancer Institute estimates that annual U.S. cancer care costs could exceed $240 billion by 2030. Perhaps the most significant cost driver today is specialty medication. Global spending on cancer medicines reached approximately $223 billion in 2023 and is projected to exceed $400 billion by 2028. Many emerging oncology drugs now carry annual treatment costs well into six figures, with certain therapies exceeding $500,000 per patient per year.
Beyond treatment expenses, employers also experience indirect costs through absenteeism, disability, reduced productivity, and the emotional toll cancer places on employees and their families.
Self-funded employers must balance cost control with providing comprehensive, high-quality care for their employees. Without a structured oncology management program, plan costs can escalate due to expensive treatments, emergency room visits, and inpatient stays.
The cancer treatment landscape is more complex than ever before. Patients may receive care from multiple specialists, treatment facilities, pharmacies, and support providers throughout their cancer journey.
Without active clinical oversight, health plans often experience:
As stop loss carriers report growing frequency and severity of oncology-related claims, employers are increasingly looking for solutions that improve outcomes while controlling costs.
In order to best support employees while keeping an eye on their bottom line, self-funded employers need to find a TPA partner who takes a whole-person approach.
Healthgram’s Oncology Management program functions as both an employee and plan advocate, offering the following benefits:
As oncology diagnoses become more prevalent and treatment costs continue to rise, cancer management has evolved from a clinical support service into a critical component of financial risk management for self-funded employers.
An effective oncology management strategy can improve member outcomes, reduce unnecessary costs, enhance the patient experience, and help protect both the health plan and stop loss performance over the long term.
Cancer care is personal. Managing it effectively should be, too.
To learn more, reach out to a member of our team.
Since 1977, Healthgram has helped self-funded employers simplify healthcare through plan administration, wellness programs, and clinical care. All built to lower employer-sponsored healthcare costs without cutting corners. The Healthgram Insights blog covers trends and insights in employer-sponsored healthcare.